Stephen K. Brannan, Chief Medical Officer at Karuna Therapeutics, Inc. (KRTX), sold 50,000 shares at $228.13 ($11.4M) on 2022-08-09, disclosed to the SEC on 2022-08-11.
Open-market sale of $11.4M KRTX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $228.05 | 12,264 | $2.8M | 24.5% |
| 2 | $228.05 | 12,264 | $2.8M | 24.5% |
| 3 | $228.10 | 5,703 | $1.3M | 11.4% |
| 4 | $228.10 | 5,703 | $1.3M | 11.4% |
| 5 | $228.13 | 7,033 | $1.6M | 14.1% |
| 6 | $228.13 | 7,033 |
| $1.6M |
| 14.1% |
| Total | $228.08 avg | 50,000 | $11.4M | 100% |
| Filing → |
| KRTX | SELL | 2024-02-12 | $3.2M | — | Filing → |
| KRTX | SELL | 2024-01-09 | $4.8M | — | Filing → |
| KRTX | SELL | 2023-12-12 | $4.0M | — | Filing → |